|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 22.28 USD | -2.28% |
|
-7.17% | +34.95% |
| 08-25 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DNLI | Delayed | |
CBOE
| DNLI | Real-time | |
|
Boerse Muenchen
| 4DN | Real-time | |
|
Tradegate
| 4DN | Real-time | |
|
Deutsche Boerse AG
| 4DN | Delayed | |
|
Börse Stuttgart
| 4DN | Delayed | |
Sao Paulo
| D2NL34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 24.2 | 27.21 | 25.83 |
| Spread/Res. | -7.93% | -18.12% | -13.74% |
| Spread/Supp. | +1.60% | +1.60% | +14.14% |
| Support | 21.93 | 21.93 | 19.52 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DNLI Stock
- Charts Denali Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
